1. Rudramurthy SM, Hoenigl M, Meis JF, Cornely OA, Muthu V, Gangneux JP, Perfect J, Chakrabarti A; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021 Sep;64(9):1028-1037.
  2. Tissot, S. Agrawal, L. Pagano, G. Petrikkos, A.H. Groll, A. Skiada, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica., 102 (2017), pp. 433-444.
  3. Skiada, L. Pagano, A. Groll, S. Zimmerli, B. Dupont, K. Lagrou, et al., Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect, 17 (2011), pp. 1859-1867,
  4. Martín Gómez MT, Salavert Lletí M. Mucormicosis: perspectiva de manejo actual y de futuro [Mucormycosis: Current and future management perspective]. Rev Iberoam Micol. 2021 Apr-Jun;38(2):91-100.
  5. Vironneau, R. Kania, G. Morizot, C. Elie, D. Garcia-Hermoso, P. Herman, et al. Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival. Clin Microbiol Infect., 20 (2014), pp. 336-339
  6. Abu El-Naaj I(1), Leiser Y, Wolff A, Peled M. The surgical management of rhinocerebral mucormycosis. J Craniomaxillofac Surg. 2013 Jun;41(4):291-5.
  7. Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-e421. doi:10.1016/S1473-3099(19)30312-3
  8. American Diabetes Association Professional Practice Committee; 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S244–S253.